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Objectives To identify risk factors for antepartum stillbirth,
including fetal growth restriction, among women with well-dated
pregnancies and access to antenatal care.
Design Population-based, prospective, observational study.
Setting Eight international urban populations.
Population Pregnant women and their babies enrolled in the
Newborn Cross-Sectional Study of the INTERGROWTH-21st
Project.
Methods Cox proportional hazard models were used to compare
risks among antepartum stillborn and liveborn babies.
Main outcome measures Antepartum stillbirth was defined as any
fetal death after 16 weeks’ gestation before the onset of labour.
Results Of 60 121 babies, 553 were stillborn (9.2 per 1000 births),
of which 445 were antepartum deaths (7.4 per 1000 births). After
adjustment for site, risk factors were low socio-economic status,
hazard ratio (HR): 1.6 (95% CI, 1.2–2.1); single marital status,
HR 2.0 (95% CI, 1.4–2.8); age ≥40 years, HR 2.2 (95% CI, 1.4–
3.7); essential hypertension, HR 4.0 (95% CI, 2.7–5.9); HIV/AIDS,
HR 4.3 (95% CI, 2.0–9.1); pre-eclampsia, HR 1.6 (95% CI, 1.1–
3.8); multiple pregnancy, HR 3.3 (95% CI, 2.0–5.6); and
antepartum haemorrhage, HR 3.3 (95% CI, 2.5–4.5). Birth weight
<3rd centile was associated with antepartum stillbirth [HR, 4.6
(95% CI, 3.4–6.2)]. The greatest risk was seen in babies not
suspected to have been growth restricted antenatally, with an HR
of 5.0 (95% CI, 3.6–7.0). The population-attributable risk of
antepartum death associated with small-for-gestational-age
neonates diagnosed at birth was 11%.
Conclusions Antepartum stillbirth is a complex syndrome
associated with several risk factors. Although small babies are at
higher risk, current growth restriction detection strategies only
modestly reduced the rate of stillbirth.
Keywords Antepartum stillbirth, birth weight, fetal growth
restriction, INTERGROWTH-21st.
Tweetable abstract International stillbirth study finds individual
risks poor predictors of death but combinations promising.
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Epidemiology
Introduction
The prevention of stillbirth remains a major global chal-
lenge. In 2015, an estimated 2.6 million babies were still-
born.1 By 28 weeks’ gestation approximately 1 in every 250
pregnancies will result in a stillbirth in high-income coun-
tries, with rates in low- and middle-income countries as
high as 1 in 22. Stillbirth is the final common endpoint of
several pathologies,2,3 yet most are unexpected and many
unexplained.4
Stillbirth is classified, according to its timing, aetiology
and possible preventive strategies, as death occurring before
the initiation of labour (antepartum) or during labour and
delivery (intrapartum). Most intrapartum stillbirths occur
because of poor-quality care during childbirth; improve-
ments in intrapartum care, closer fetal monitoring and
access to operative delivery have dramatically reduced the
number of such deaths.5,6 However, the prevention of
antepartum stillbirths has proved to be more challenging.
First, the pathways linking clinical and pregnancy condi-
tions to antepartum stillbirth are poorly understood, mak-
ing it difficult to screen women at increased risk in whom
interventions could potentially be implemented. Second,
while antepartum stillbirth has been associated with socio-
demographic factors and medical conditions,7–12 most
studies report associations that are not sufficiently strong
and that are of uncertain relevance outside their specific
population. Finally, fetal growth restriction (FGR) is fre-
quently cited as preceding antepartum stillbirth;5–9 how-
ever, the magnitude of the causal association is difficult to
ascertain, as FGR is almost always diagnosed retrospectively
based on weight at birth.
Our primary aim in this study was to investigate risk
factors specific for antepartum stillbirth, including poor
fetal growth, in a large, population-based study of fetal
growth and pregnancy outcome among women with ultra-
sound-dated pregnancies who were receiving good antena-
tal care in eight urban areas around the world.13
Methods
Study design and participants
The Newborn Cross-Sectional Study (NCSS) component
of the INTERGROWTH-21st Project was a large, multi-
country, multi-ethnic, population-based study conducted
between May 14 2009 and August 2 2013. The primary
aim was to study fetal growth and development from early
pregnancy until 2 years of age.13 Populations were selected
at the cluster level. Study protocols with detailed criteria
for population selection have been previously published.14–
21 Clusters were defined as urban areas, representing either
a complete city or a demarcated geographical or political
area within a city, where most women accessed antenatal
care and delivered in medical facilities; altitude was
≤1600 m; perinatal mortality rate was <20 per 1000 live
births; mean birthweight was >3100 g; and low-birth-
weight rates (<2500 g) were <10%. In addition, >75% of
mothers had an educational level greater than a locally
defined minimum threshold and there was an absence of
known, major, environmental contaminants assessed using
a specifically designed data collection form.22 Sites selected
were: the cities of Pelotas, Brazil; Turin, Italy; Muscat,
Oman; Oxford, UK; Seattle, WA, USA; Shunyi County in
Beijing, China; the central area of Nagpur, Maharashtra,
India; and the Parklands suburb of Nairobi, Kenya.
Within these sites, hospitals and clinics were selected to
ensure coverage of at least 80% of births. All participating
hospitals agreed to a policy of routinely estimating gesta-
tional age using ultrasound before 24 weeks’ gestation
with a strict, standardised protocol to measure either fetal
crown–rump length (if ≤14 weeks’ gestation) or head cir-
cumference (if >14 and ≤24 weeks’ gestation).13 Informa-
tion was obtained on all births from 16 weeks’ gestation.
Stillbirth was defined as fetal death between 16 weeks and
birth, in keeping with our previous publications on pre-
term birth.23
Independent variables
Data were prospectively collected using a standardised col-
lection form and a secure online data entry and manage-
ment system (MedSciNet).24 Low socio-economic status
was country specific. Smoking was defined as any tobacco
use in the current pregnancy; alcohol intake was recorded
if >5 units per week. Full descriptions are available from
the study website, www.intergrowth21.tghn.org.
Outcomes from previous pregnancies were self-reported.
Pregnancy-induced hypertension was defined as blood
pressure ≥140/90 mmHg, after 20 weeks’ gestation in a
previously normotensive woman without proteinuria. Pre-
eclampsia was defined by consensus as blood pressure
≥140/90 mmHg, or an increase of 30 mmHg systolic or
15 mmHg diastolic over baseline, detected on at least two
occasions more than 6 hours apart, associated with pro-
teinuria after 20 weeks’ gestation. Severe pre-eclampsia/
eclampsia/HELLP (Haemolysis, Elevated Liver enzymes and
Low Platelet count) syndrome was defined as blood pres-
sure ≥160 mmHg systolic and/or ≥110 mmHg diastolic on
two occasions at least 4 hours but no more than 168 hours
apart, or if the first measurement was immediately followed
by treatment with an antihypertensive, either of these sce-
narios being associated with proteinuria. Eclampsia was
defined as the occurrence of convulsions unrelated to other
cerebral conditions with symptoms or signs of pre-eclamp-
sia. Antepartum fetal distress was defined on the basis of
clinical suspicion with or without non-invasive fetal moni-
toring.
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We explored the relationship between FGR, small-for-
gestational-age (SGA) at birth, and antepartum stillbirth
using three approaches. First, the relationship between the
detection of FGR during pregnancy and antepartum still-
birth was examined. Detected FGR was defined as docu-
mented poor fetal growth prior to death, based either on
ultrasound evidence of poor serial growth, or size/abdomi-
nal circumference <10th centile with abnormal Doppler
studies. Second, the association between stillbirth and SGA
at birth, defined as birth weight <3rd centile for gestational
age, and gender for babies born after 24 weeks using the
INTERGROWTH-21st Newborn Size at Birth Standards,
was assessed.25 Third, we evaluated the ultrasound growth
trajectories for the stillbirths that occurred within the Fetal
Growth Longitudinal Study (FGLS) of the INTER-
GROWTH-21st Project.13 A subset was selected of 4607
women who were at low risk, at the individual level, of
growth problems at the start of pregnancy, and who were
monitored with serial ultrasound scans every 5 weeks until
delivery.26
Statistical analysis
The sample size was based on the primary objective.27 In a
post-hoc estimation for 440 antepartum stillbirths with a
5% prevalence of risk factors, a relative risk of 2.1 could be
demonstrated with 80% power, and statistical significance
was set at a two-tailed P of <0.05.
We estimated total stillbirth (antepartum and intra-
partum) rates per 1000 live- and stillborn babies delivered
after 16 weeks’ gestation. We performed time-to-event
analysis using Cox Proportional Hazard Models. Antepar-
tum stillbirth was defined as the event and gestational age
in weeks was the time-dependent variable. Preterm births
were censored. This is the recommended method for still-
birth analysis, as it accounts for the cumulative risk of
death with ongoing duration of pregnancy.28,29 In order to
account for clustering within sites, all hazard ratios (HR)
were adjusted for country using the UK as the reference.
An exploratory analysis was performed to identify associa-
tions between potential risk factors and antepartum still-
birth, compared with live births. Variables with fewer than
five cases are not presented.30 Variables missing more than
5% of responses were excluded from further models (i.e.
maternal education). Exclusion of education avoided multi-
colinearity with socio-economic status. The proportional
hazard assumption was tested using Shoenfeld residuals,
which were plotted against each covariate and the graphs
inspected for any trend in the residuals.
We used a hierarchical approach to model building for
confounder selection.31 This approach recognises that distal
disease determinants such as socio-economic factors can
potentially affect all other variables as well as the outcome
(antepartum stillbirth) directly or indirectly. In addition,
the relationship between variables is often temporal, with
most standard regression methods failing to take this into
account. Adopting a hierarchical approach helps to ensure
that distal determinant effects on the outcome are not
underestimated.32 A directed acyclic graph was developed
based on known clinical associations (Figure S1). Sequen-
tial models incorporated variables from the preceding
model only if P was <0.2.33 Biologically plausible interac-
tion terms were identified a priori, and only retained if
P < 0.05, with effect consistent with action.
Positive (LR+) and negative (LR) likelihood ratios were
computed if an association with antepartum stillbirth was
found in the multivariate models, and for plausible risk-
factor combinations. LRs remain constant despite differing
risk-factor prevalence and are, therefore, clinically useful in
interpreting how a variable changes the post-test probabil-
ity of disease. LRs between 2 and 5 (or LRs 0.5 and 0.2 for
protective factors) are accepted indicators of a small change
in the post-test probability of a condition, between 5 and
10 (0.2 and 0.1) a moderate change in risk, and above 10
(below 0.1) a large change.34
Attributable risk (%) in the total population was esti-
mated as the proportion of antepartum stillbirths that
could potentially be reduced by eliminating a risk factor.
Statistical calculations were performed using SPSS Statistics
version 21 (IBM, Armonk, NY, USA).
Results
Study population
Across the eight study sites, 59 137 women delivered
60 268 babies. We excluded 105 babies with unknown ges-
tational age at delivery, 15 with gestational age <16 weeks,
and 27 born after 43 weeks. Thus, 60 121 babies born to
59 052 mothers were included, ranging from 6431 babies
in Seattle, USA, to 8206 in Oxford, UK. Descriptive charac-
teristics of the mothers and babies are presented in
Table S1.
A total of 59 568 (singleton 57 508, multiple 2060) were
liveborn and 553 (511 singleton, 42 multiple) were stillborn
(overall stillbirth rate 9.2 per 1000 live and stillborn babies,
range 5.1–15.1 across sites). Of all the stillbirths, 445 (sin-
gleton 413, multiple 32) were antepartum and 108 (single-
ton 98, multiple 10) were intrapartum. The overall late
fetal death rate according to the WHO definition
(>28 weeks’ gestation) was 5.4 (range, 3.1–9.1 across sites).
Antepartum stillbirth accounted for a high proportion of
fetuses born before 24 weeks’ gestation (98 deaths; 73.1%
of all births before 24 weeks); 168 (37.8%) of the antepar-
tum stillborn babies delivered after 33 weeks.
Among the antepartum stillbirths, 14 (3.1%) had con-
genital malformations diagnosed either at birth or by ultra-
sound during pregnancy (Table S2).
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Table 1. Association of maternal factors with antepartum stillbirth in a population of 60 121 babies in the INTERGROWTH-21st Project
Variable Adjusted hazard ratio
(95% CI)
Population-attributable
percentage (%)
Low socio-economic standing 1.6 (1.2–2.1)* 9.7
Single marital status 2.0 (1.4–2.8)* 4.8
Maternal age (years)
<18 0.8 (0.4–1.6)**
18–25 Ref
26–34 1.1 (0.9–1.4)**
35–39 1.2 (0.8–1.7)**
≥40 2.2 (1.4–3.7)** 3.0
Prior history of hypertension 4.0 (2.7–5.9)*** 5.5
HIV/AIDS diagnosed before pregnancy 4.3 (2.0–9.1)*** 0.3
Last two pregnancies ended in miscarriage 1.8 (1.1–3.0)*** 4.3
Pre-eclampsia 1.6 (1.1–3.8)**** 1.4
Severe pre-eclampsia/eclampsia/HELLP without antepartum haemorrhage 2.8 (1.5–5.1)**** 1.6
Severe pre-eclampsia/eclampsia/HELLP with antepartum haemorrhage 4.2 (1.3–13.6)**** 2.2
Antepartum haemorrhage without severe pre-eclampsia 3.3 (2.5–4.5)**** 9.0
Multiple pregnancy 3.3 (2.0–5.6)**** 7.4
Fetal distress suspected in pregnancy 2.1 (1.3–2.7)***** 3.4
All models adjusted for country of birth and fetal gender. In addition, the following stepwise adjustments were made: *Model 1, socio-economic
deprivation and marital status; **Model 2, I < 0.2 in Model 1 + maternal age, body mass index, height, weight, parity + smoking, illicit drug
use, >5 units of alcohol per week + high-risk occupation; ***Model 3, P < 0.2 in Model 2+ pre-existing maternal medical conditions and past
obstetric outcomes; ****Model 4, P < 0.2 in Model 3 + maternal illnesses and conditions that develop during in pregnancy; *****Model 5,
P < 0.2 in Model 4+ fetal-related conditions.
Table 2. Liklihood ratios for risk factors associated with antepartum stillbirth in a population of 60 121 babies in the INTERGROWTH-21st Project
Risk factor Antepartum
stillbirth (%)
Live birth (%) Positive
LR (95% CI)
Negative
LR (95% CI)
Low socio-economic standing 34.6 22.7 1.5 (1.3–1.7) 0.9 (0.8–0.9)
Single marital status 11.2 5.0 2.3 (1.7–2.9) 0.9 (0.9–1.0)
Maternal age ≥40 years 5.0 2.4 2.1 (1.4–3.1) 1.0 (1.0–1.0)
Pre-existing hypertension 7.7 1.8 4.5 (3.2–6.3) 1.0 (1.0–1.0)
HIV/AIDS diagnosed prior to pregnancy 1.6 0.3 5.5 (2.7–11.5) 1.0 (1.0–1.0)
Last two pregnancies ended in miscarriage 6.1 3.4 1.8 (1.2–2.6) 1.0 (1.0–1.0)
Bleeding after 15 weeks’ gestation 13.7 4.4 3.1 (2.5–4.0) 0.9 (0.9–0.9)
Pre-eclampsia 6.1 2.4 2.5 (1.7–3.7) 1.0 (0.9–1.0)
Severe pre-eclampsia/ HELLP/ eclampsia 3.9 0.8 5.0 (3.1–8.1) 1.0 (1.0–1.0)
Multiple pregnancy 7.2 3.4 2.1 (1.5–3.0) 1.0 (0.9–1.0)
Fetal distress suspected in pregnancy 4.0 1.7 2.4 (1.5–3.7) 1.0 (1.0–1.0)
FGR suspected in pregnancy* 10.1 4.4 2.3 (1.7–3.2) 0.9 (0.9–1.0)
SGA at birth* 16.7 3.5 4.8 (3.8–6.1) 0.9 (0.8–0.9)
Selected risk factor combinations:
Single marital + antepartum haemorrhage 2.5 0.5 5.2 (2.9–9.4) 1.0 (1.0–1.0)
Maternal age >40+ pre-existing hypertension 2.7 0.2 14.0 (7.8–25.0) 1.0 (1.0–1.0)
Pre-eclampsia + suspected FGR 2.0 0.3 6.8 (3.5–13.0) 1.0 (1.0–1.0)
Severe pre-eclampsia/eclampsia/HELLP +
antepartum haemorrhage
0.9 0.0 31.0 (13.0–73.0) 0.8 (0.6–1.0)
Multiple pregnancy + suspected fetal distress 1.6 0.1 16.0 (7.2–34.0) 1.0 (1.0–1.0)
FGR, fetal growth restriction; LR, likelihood ratio; SGA, small-for-gestational-age.
*For babies born after 24 weeks only.
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Epidemiological associations and prognostic
factors for antepartum stillbirth
No significant association with antepartum stillbirth was
demonstrated with smoking, reported illicit drug use, high-
risk occupation or body mass index (Table S3). Women
with a history of either a previous perinatal loss, preterm
delivery, a baby born with high (>4500 g) or low
(<2500 g) birthweight, or miscarriages in the preceding
two pregnancies, had a higher risk of antepartum stillbirth
(Table S4). When pregnancy-related conditions were exam-
ined (Table S5), there was an increasing risk of stillbirth
with severity of hypertensive disease, i.e. pregnancy-induced
hypertension increased the HR of antepartum stillbirth by
1.75, pre-eclampsia by 3.23 and severe pre-eclampsia/
HELLP/eclampsia by 5.53.
After adjustment for potential confounders including
study site, low socio-economic standing and single marital
status showed independent associations with antepartum
stillbirth; single, widowed or divorced women were at twice
the risk of antepartum stillbirth than were those married or
cohabiting (adjusted HR, 2.00) (Table 1). Maternal age of
at least 40 also doubled the risk compared with that of
mothers aged between 18 and 25 years (adjusted HR, 2.23).
Prior essential hypertension or HIV/AIDS both increased
HR of antepartum stillbirth approximately fourfold (ad-
justed HR, 3.98 and 4.26, respectively). Women who had
previously had two miscarriages had a modest increase in
risk (adjusted HR, 1.82). Bleeding in pregnancy was both
an independent risk (adjusted HR, 3.33), and potential
effect modifier of the effect of severe pre-eclampsia,
increasing the adjusted HR from 2.80 to 4.20. The highest
population-attributable percentages for individual risk fac-
tors were for low socio-economic standing (9.7%), antepar-
tum haemorrhage (9.0%) and multiple pregnancy (7.4%).
The overall cumulative probability of antepartum still-
birth in this population was 0.007 (Table 2). The highest
probabilities of antepartum stillbirth were for women with
the combinations of severe pre-eclampsia and antepartum
haemorrhage (APH) (probability 0.18, LR+ 31); in multiple
pregnancies where fetal distress was suspected (probability
0.10, LR+ 16.0), and in women aged >40 with a history of
essential hypertension [probability 0.09, LR+ 14.0 (95% CI,
7.76–25.0)]. All other risk factors explored demonstrated
relatively weak associations, with poor negative predictive
ability (LR all close to 1.0).
Association between fetal growth restriction and
antepartum stillbirth
In the entire INTERGROWTH-21st population, evidence of
altered growth or small fetal size on ultrasound doubled
the risk of antepartum stillbirth [adjusted HR, 2.1 (95%
CI, 1.4 –3.1)]. In addition, we studied the association
between antepartum stillbirth and small size at birth. Still-
born babies were more likely to be SGA at birth [16.8%
compared with 3.5% for babies born after 24 week’ gesta-
tion, with an adjusted HR of 4.6 (95% CI, 3.4–6.2)]
(Table 3). Interestingly, among the SGA babies at birth, if
FGR was identified during pregnancy, the risk of stillbirth
was lower than for those babies in whom growth restriction
was not suspected [adjusted HR 3.5 (95% CI, 1.9–6.4),
compared with HR 5.0 (95% CI, 3.6–7.0)], suggesting, per-
haps, that effective action had been implemented in these
women. The population-attributable risk for stillbirth asso-
ciated with SGA at birth in the entire INTRGROWTH-21st
population was 11%. If we were able to ‘transform’ all FGR
not suspected before birth to ‘suspected’ FGR then the
attributable risk for them would have been 9%.
We conducted a detailed subgroup analysis among the
4607 women in the low-risk FGLS cohort for whom serial
ultrasound data were available. Among the 18 antenatal
stillbirths that were tracked, their ultrasound parameters
were almost all within the 3rd and 97th centiles of the
INTERGROWTH-21st fetal growth standards. No evidence
of decreased velocity in either skeletal growth (head
Table 3. Association between fetal growth restriction and antepartum stillbirth in a population of 59 792 babies in the INTERGROWTH-21st
Project
Variable Prevalence (%) Adjusted HR Population-
attributable risk (%)
Liveborn (n = 59 445) Stillborn (n = 347)
FGR suspected during pregnancy 4.4 10.1 2.1 (1.4–3.1)
SGA at birth 3.5 16.7 4.6 (3.4–6.2) 11.1
SGA at birth: FGR suspected during pregnancy 0.9 3.5 3.5 (1.9–6.4) 2.2
SGA at birth: FGR not suspected during pregnancy 2.6 13.3 5.0 (3.6–7.0) 9.4
HR, hazard ratio.
FGR defined as an antenatal diagnosis of growth restriction based upon ultrasound findings of poor interval growth or estimated weight or AC
<10th centile for gestational age with abnormal functional studies. SGA defined as birth weight <3rd centile for gestational age and gender using
the INTERGROWTH-21st Newborn Size at Birth Standards, adjusted for study country and other conditions listed in Table 2.
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circumference) or fat-dependent measures (abdominal cir-
cumference) could be demonstrated among these 18 fetuses
that died before labour (Figure 1).
Discussion
Main findings
The principal results from our multi-country study of
antepartum stillbirth are that: (1) the rate can be as low as
10 per 1000 births when adequate health care, education,
nutrition and maternity care are provided to a population;
(2) the several known clinical and demographic factors
identified are individually relatively poor predictors of
antepartum death; (3) the attributable fraction of antepar-
tum death that could be prevented by modifying these
individual risk factors is <10%; (4) in the general popula-
tion, FGR is a risk factor for antepartum stillbirth; however
among women at low risk who were followed with repeated
ultrasound measurements, abnormal growth may play a
lesser role in leading to stillbirth.
Of clinical relevance are the predictive probabilities of
combinations of risk factors, e.g. women aged 40 or older
with essential hypertension, those with multiple pregnan-
cies who develop fetal distress and those with pre-eclampsia
who experience APH.
Strengths and limitations of the study
Our study has several strengths: there was high (>80%)
coverage of all births within the target populations as
defined by geographic and social criteria,35 and we
differentiated between antepartum and intrapartum still-
birth, which are clearly separate entities. Any definition of
stillbirth that fails to differentiate these entities, although
simpler for routine data collection, has limited value for
evaluating and implementing preventive strategies. We also
describe antepartum stillbirth from 16 weeks’ gestation in
eight diverse locations around the world where women had
access to early dating by ultrasound, providing a more
comprehensive view of this entity than those limited to tra-
ditional definitions, i.e. those including only late antepar-
tum death. We applied a high degree of methodological
standardisation to ensure the collection of robust, unbiased,
clinical and demographic data, including gestational age
dating by early ultrasound, and used a hierarchical
approach to analysis that demonstrated the importance of
distal determinants on antepartum stillbirth. We also pre-
sent risk models based on common risk factors that could
be introduced into clinical practice immediately.
Pathological and microbiological examinations of the
fetus/placenta were not performed in NCSS. Placental
histopathology, although retrospective, can be useful for
confirming the likely cause(s) of death in some cases of
stillbirth.36 Therefore, we acknowledge that a limitation of
this study is that we cannot claim the conditions we exam-
ined were causal. Instead, what we present are prognostic
factors that, either singularly or in combination, increase
the risk of stillbirth. In future studies, it is hoped that use
of the new International Classification of Disease (ICD-11)
will provide a universally applicable, standard classification
system for stillbirths that can be applied in settings with
and without access to pathology.
Interpretation
Our data demonstrate that poor fetal growth and SGA at
birth, particularly when not suspected during pregnancy, are
asociated with antepartum stillbirth.9 However, this associa-
tion was less evident in the subset of women with longitudi-
nal ultrasound data, selected as they were, for low risk of
growth problems. It is possible that, by using SGA based on
weight at birth (as a proxy for FGR), the contribution of FGR
to stillbirth may be overestimated, as fetuses lose weight after
death.37 While some studies have attempted to correct for this
potential bias,38 in clinical practice the exact time of death is
rarely known. While we acknowledge that the number of
cases of stillbirth was small in the low-risk group, we cannot
exclude the possibility that babies exhibiting poor growth
were delivered earlier based on this finding. It should be
borne in mind, however, that not all the pathways leading to
antepartum stillbirth are chronic enough to cause an alter-
ation in growth velocity, highlighting the heterogenous nat-
ure of this complex syndrome. This is important when
evaluating the role of routine third-trimester ultrasound scans
to prevent antepartum stillbirth in low-risk populations.
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Figure 1. Individual growth trajectories of 18 babies who were stillborn
in the Fetal Growth Longitudinal Study. Dashed black lines represent
10th, 50th and 90th centiles of the INTERGROWTH-21st Fetal Growth
Standards (stillbirths were excluded from the calculation of these
values).
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In our study population, the overall attributable risk of
SGA for antepartum stillbirth was 11%, i.e. only 11% of all
antepartum deaths could be prevented by eliminating all
cases of FGR, which is in itself impossible. However, given
that correct antenatal detection of SGA in the whole popu-
lation was 27% – a rate consistent with that in the litera-
ture – the impact of screening low-risk women for FGR to
reduce stillbirth may be very limited.
The Every Newborn Action Plan 2014 has set a target for
all countries to achieve stillbirth rates of <10 per 1000
births (after 28 weeks’ gestation) by 2035.39 We believe that
this target is achievable across the world provided that the
social, nutritional and health-care needs of women are met.
The disparities currently seen in stillbirth rates among
countries mostly reflect differences in population health,
nutritional status, reporting systems and access to care, and
are less likely to be related to any underlying ethnic or
genetic differences.6
Our findings reinforce recommendations to improve the
detection and management of hypertensive disorders of
pregnancy and other pregnancy conditions including the
association with FGR. It is noteworthy, however, that sev-
eral of the ‘lifestyle’ risk factors that have previously been
associated with stillbirth, such as obesity and smoking,
were not independently associated in this population. This
is probably owing to the relatively low prevalence of these
conditions in some of the study sites, emphasising the
importance of context.
Although we focused on antepartum stillbirth, intra-
partum stillbirth still accounted for 20% of deaths in our
study, compared to the global figure of around 45%.5 Pro-
viding all women with access to high-quality intrapartum
care remains crucial; however, our study emphasises that
improving intrapartum care alone will not be enough to
reduce all preventable deaths. The evidence we present on
clinical risk-factor associations adds to the developing
knowledge of other types of prediction models to identify
pregnancies at risk of stillbirth, from biomarkers and uter-
ine blood flow studies. For example, there is a suggestion
that low serum levels of pregnancy-associated plasma pro-
tein-A during the first trimester and an increased pulsatility
index from Doppler ultrasonography during the second tri-
mester could be good predictors of stillbirth, with a moder-
ate LR+ ranging from 10.0 to 15.0.40 The presence of these
risk factors, in addition to the patterns of clinical variables
we have reported, could guide decision-making about the
timing of delivery to prevent antepartum stillbirth.
Conclusion
We have confirmed that antepartum stillbirth is a complex
syndrome that requires comprehensive interventions to
meet the social, nutritional and health-care requirements of
all pregnant women worldwide. The promotion of inter-
ventions that are targeted at only one risk factor is unlikely
to make a large impact on rates of antepartum stillbirth.
Combinations of risk prediction models, biomarkers and
growth trajectories could help to identify women at risk of
specific forms of stillbirth.
Disclosure of interests
None declared. Completed disclosure of interests form
available to view online as supporting information.
Contribution to authorship
All authors are members of the INTERGROWTH-21st Con-
sortium and developed the conceptual ideas for the
planned secondary analyses of the INTERGROWTH-21st
Project. JEH and DF wrote the first versions of the manu-
script with subsequent contributions from JV, SHK, CGV,
FCB, AL and ZAB. JV and SHK are the co-directors of the
INTERGROWTH-21st Project; LCI was the Project Leader;
ATP was the ultrasound lead and JAN the engineering lead
for ultrasound standardisation across sites; MGG, FG, MP,
FCB, IOF, RP, WS and YAJ implemented the study in their
respective countries and were responsible for site coordina-
tion, data collection and integrity. DGA and EOO were the
medical statisticians for the INTERGROWTH-21st Project.
All co-authors read the report and approved the final
manuscript.
Ethical approval
The INTERGROWTH-21st Project was approved by the
Oxfordshire Research Ethics Committee ‘C’ (reference:08/
H0606/139) in December 2008, the research ethics committees
of the individual participating institutions, and corresponding
health authorities where the project was implemented.
Funding
The INTERGROWTH-21st Project was supported by a
grant from the Bill and Melinda Gates Foundation. The
sponsor had no role in the study design, data collection,
analysis or interpretation or in the writing of the report.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. The hierarchical approach to analysis for still-
birth using a directed acyclic approach.
Table S1. Descriptive characteristics of the mothers and
babies.
Table S2. Details of congenital abnormalities detected in
antepartum death.
Table S3. Maternal characteristics comparing antepartum
stillborn with live born babies.
1151ª 2016 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists
Antepartum stillbirth syndrome
Table S4. Associations between Maternal past medical
and obstetric history and antepartum stillbirth.
Table S5. Conditions first detected in pregnancy and
pregnancy-specific conditions and antepartum stillbirth.&
References
1 Blencowe H, Cousens S, Jassir FB, Say L, Chou D, Mathers C, et al.
National, regional, and worldwide estimates of stillbirth rates in
2015, with trends from 2000: a systematic analysis. Lancet Glob
Health 2016;4:e98–108.
2 Froen JF, Pinar H, Flenady V, Bahrin S, Charles A, Chauke L, et al.
Causes of death and associated conditions (Codac): a utilitarian
approach to the classification of perinatal deaths. BMC Pregnancy
Childbirth 2009;9:22.
3 Headley E, Gordon A, Jeffery H. Reclassification of unexplained
stillbirths using clinical practice guidelines. Aust NZ J Obstet
Gynaecol 2009;49:285–9.
4 de Bernis L, Kinney MV, Stones W, Ten Hoope-Bender P, Vivio D,
Leisher SH, et al. Stillbirths: ending preventable deaths by 2030.
Lancet 2016;387:703–16.
5 Lawn JE, Lee AC, Kinney M, Sibley L, Carlo WA, Paul VK, et al. Two
million intrapartum-related stillbirths and neonatal deaths: where,
why, and what can be done? Int J Gynaecol Obstet 2009;107(Suppl
1):S5–18, S19.
6 Bhutta ZA, Yakoob MY, Lawn JE, Rizvi A, Friberg IK, Weissman E,
et al. Stillbirths: what difference can we make and at what cost?
Lancet 2011;377:1523–38.
7 Flenady V, Koopmans L, Middleton P, Froen JF, Smith GC, Gibbons
K, et al. Major risk factors for stillbirth in high-income countries:
a systematic review and meta-analysis. Lancet 2011;377:
1331–40.
8 Fretts R. Etiology and prevention of stillbirth. Am J Obstet Gynecol
2005;193:1923–35.
9 Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A.
Maternal and fetal risk factors for stillbirth: population based study.
BMJ 2013;346:f108.
10 McCowan L, George-Haddad M, Stacey T, Thompson J. Fetal
growth restriction and other risk factors for stillbirth in a New
Zealand setting. Aus NZ J Obstet Gynaecol 2007;47:450–6.
11 Gordon A, Raynes-Greenow C, McGeechan K, Morris J, Jeffery H.
Risk factors for antepartum stillbirth and the influence of maternal
age in New South Wales Australia: a population based study. BMC
Pregnancy Childbirth 2013;13:12.
12 Stillbirth Collaborative Research Network Writing Group. Association
between stillbirth and risk factors known at pregnancy confirmation.
JAMA 2011;306:2469–79.
13 Villar J, Altman DG, Purwar M, Noble JA, Knight HE, Ruyan P, et al.
The objectives, design and implementation of the INTERGROWTH-
21st Project. BJOG 2013;120(Suppl 2):9–26.
14 Giuliani F, Bertino E, Oberto M, Di Nicola P, Gilli G, Knight H, et al.
Implementation of the INTERGROWTH-21st Project in Italy. BJOG
2013;120(Suppl 2):100–4.
15 Roseman F, Knight HE, Giuliani F, Lloyd S, Di Nicola P, Laister A,
et al. Implementation of the INTERGROWTH-21st Project in the UK.
BJOG 2013;120(Suppl 2):117–22.
16 Carvalho M, Vinayak S, Ochieng R, Choksey V, Musee N, Stones W,
et al. Implementation of the INTERGROWTH-21st Project in Kenya.
BJOG 2013;120(Suppl 2):105–10.
17 Jaffer YA, Al Abri J, Abdawani J, Knight HE, Cheikh Ismail L,
International F, et al. Implementation of the INTERGROWTH-21st
Project in Oman. BJOG 2013;120(Suppl 2):111–16.
18 Pan Y, Wu MH, Wang JH, Pang RY, Knight HE, Cheikh Ismail L,
et al. Implementation of the INTERGROWTH-21st Project in China.
BJOG 2013;120(Suppl 2):87–93.
19 Purwar M, Kunnawar N, Deshmukh S, Singh A, Mulik I, Taori V,
et al. Implementation of the INTERGROWTH-21st project in India.
BJOG 2013;120(Suppl 2):94–9.
20 Silveira MF, Barros FC, Sclowitz IK, Domingues MR, Mota DM,
Fonseca SS, et al. Implementation of the INTERGROWTH-21st Project
in Brazil. BJOG 2013;120(Suppl 2):81–6.
21 Dighe MK, Frederick IO, Andersen HF, Gravett MG, Abbott SE,
Carter AA, et al. Implementation of the INTERGROWTH-21st Project
in the United States. BJOG 2013;120(Suppl 2):123–8.
22 Eskenazi B, Bradman A, Finkton D, Purwar M, Noble JA, Pang R,
et al. A rapid questionnaire assessment of environmental exposures
to pregnant women in the INTERGROWTH-21st Project. BJOG
2013;120(Suppl 2):129–38.
23 Villar J, Papageorghiou AT, Knight HE, Gravett MG, Iams J, Waller
SA, et al. The preterm birth syndrome: a prototype phenotypic
classification. Am J Obstet Gynecol 2012;206:119–23.
24 Ohuma EO, Hoch L, Cosgrove C, Knight HE, Cheikh Ismail L,
Juodvirsiene L, et al. Managing data for the international,
multicentre INTERGROWTH-21st Project. BJOG 2013;120(Suppl
2):64–70.
25 Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman
DG, et al. International standards for newborn weight, length, and
head circumference by gestational age and sex: the Newborn Cross-
Sectional Study of the INTERGROWTH-21st Project. Lancet
2014;384:857–68.
26 Papageorghiou AT, Kennedy SH, Salomon LJ, Ohuma EO, Cheikh
Ismail L, Barros FC, et al. International standards for early fetal size
and pregnancy dating based on ultrasound measurement of crown–
rump length in the first trimester. Ultrasound Obstet Gynecol
2014;44:641–8.
27 Altman DG. Ohuma EO; International Fetal and Newborn Growth
Consortium for the 21st Century. Statistical considerations for the
development of prescriptive fetal and newborn growth standards in
the INTERGROWTH-21st Project. BJOG 2013;120(Suppl 2):71–6.
28 Platt RW, Joseph KS, Ananth CV, Grondines J, Abrahamowicz M,
Kramer MS. A proportional hazards model with time-dependent
covariates and time-varying effects for analysis of fetal and infant
death. Am J Epidemiol 2004;160:199–206.
29 Smith GC. Estimating risks of perinatal death. Am J Obstet Gynecol
2005;192:17–22.
30 Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per
variable in logistic and Cox regression. Am J Epidemiol
2007;165:710–8.
31 Victora CG, Huttly SR, Fuchs SC, Olinto MT. The role of conceptual
frameworks in epidemiological analysis: a hierarchical approach. Int J
Epidemiol 1997;26:224–7.
32 Victora CG, Fuchs SC, Flores JA, Fonseca W, Kirkwood B. Risk
factors for pneumonia among children in a Brazilian metropolitan
area. Pediatrics 1994;93:977–85.
33 Maldonado G, Greenland S. Simulation study of confounder-
selection strategies. Am J Epidemiol 1993;138:923–36.
34 Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood
ratios. Lancet 2005;365:1500–5.
35 Szklo M. Population-based cohort studies. Epidemiol Rev
1998;20:81–90.
36 Tellefsen CH, Vogt C. How important is placental examination in
cases of perinatal deaths? Pediatr Dev Pathol 2011;14:99–104.
37 Sebire NJ. Detection of fetal growth restriction at autopsy in non-
anomalous stillborn infants. Ultrasound Obstet Gynecol
2014;43:241–4.
1152 ª 2016 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists
Hirst et al.
38 Conway DL, Hansen NI, Dudley DJ, Parker CB, Reddy UM, Silver RM,
et al. An algorithm for the estimation of gestational age at the time
of fetal death. Paediatr Perinat Epidemiol 2013;27:145–57.
39 Lawn JE, Blencowe H, Oza S, You D, Lee AC, Waiswa P, et al. Every
Newborn: progress, priorities, and potential beyond survival. Lancet
2014;384:189–205.
40 Conde-Agudelo A, Bird S, Kennedy SH, Villar J, Papageorghiou AT.
First- and second-trimester tests to predict stillbirth in unselected
pregnant women: a systematic review and meta-analysis. BJOG
2015;122:41–55.
1153ª 2016 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists
Antepartum stillbirth syndrome
